ClinicalTrials.gg
Biological

Rabies virus strain flury LEP antigen (propiolactone inactivated) clinical trials

Also written RabAvert and Rabipur.

studies test it
11
open now
1
in phase 3
2
first study started
2002

How each study uses rabies virus strain flury LEP antigen (propiolactone inactivated) is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the rabies virus strain flury LEP antigen (propiolactone inactivated) studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Brand

RabAvert
5

Other names

Rabipur
4

Studies by the year they started

11 studies that test it; most in 2002 (1)

Studies that test rabies virus strain flury LEP antigen (propiolactone inactivated), by start year
YearStudies
20021
20061
20081
20091
20131
20141
20161
20171
20181
20211
20261

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
2
Phase 3
2
Phase 4
3
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 7

U.S. Army Medical Research and Development Command (2) · Centers for Disease Control and Prevention (1) · London School of Hygiene and Tropical Medicine (1) · Kamada, Ltd. (1) · Synermore Biologics Co., Ltd. (1) · CureVac (1) · Washington University School of Medicine (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)

Often tested with

Tested in the same studies.

SYN023 (1) · Rabies virus strain PM-1503-3M antigen (propiolactone inactivated) (1) · CV-8102 (1) · Influenza Vaccines (1) · Pneumococcal Vaccines (1) · Heptavalent Pneumococcal Conjugate Vaccine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test rabies virus strain flury LEP antigen (propiolactone inactivated).

Studies

Open first, then newest update. How each study uses rabies virus strain flury LEP antigen (propiolactone inactivated) is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Given beside what is tested · 4 — rabies virus strain flury LEP antigen (propiolactone inactivated) is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with rabies virus strain flury LEP antigen (propiolactone inactivated)

What changed recently

From the registry's own updates since Oct 22, 2026.

Codes

What other systems call rabies virus strain flury LEP antigen (propiolactone inactivated) · ClinicalTrials.gg INT016568

  • UNII (FDA) FK894Q51YERABIES VIRUS STRAIN FLURY LEP ANTIGEN (PROPIOLACTONE INACTIVATED)One source FDA
  • RxNorm 830457One source FDA
  • NCI Thesaurus C75812Rabies Virus Strain Flury LEP Antigen (Propiolactone Inactivated)One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.